Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes
International Journal of Molecular Sciences · 31.03.2026 · 27 (7) · 3160
DOI: 10.3390/ijms27073160 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.03.2026. Verfasst von Chen Ifrach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Molecular Medicine, Barzilai University Medical Center, Ashkelon 78278, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Diabetes Mellitus, Experimental. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional funds.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Individuals may be prone or resistant to the development of type 2 diabetes. The basis for susceptibility is in part genetic, but environmental factors are likely to come into play. The gut microbiome stands at the interface of genetics and the host microenvironment. Its role in mediating susceptibility to diabetes, however, has not been resolved. Here we investigated whether the gut microbial composition contributes to susceptibility to diabetes, as distinct from disease development. We hypothesized that distinct microbial signatures modulate sensitivity or resistance to a diabetogenic diet (DD) and that separate signatures are linked to disease development. To test this hypothesis, we studied the Cohen diabetic rat model, comprising a diabetes-sensitive strain (CDs/y) and a diabetes-resistant strain (CDr/y). When exposed to DD, diabetes develops in CDs/y but not in CDr/y rats; on a regular diet (RD), both strains remain metabolically normal. To establish the contribution of the gut microbiome to susceptibility, we studied the fecal microbial composition in young, metabolically healthy CDs/y and CDr/y rats, using 16S rRNA gene sequencing, measures of α- and β-diversity, and differential taxonomic abundance. We found distinct, strain-specific gut microbiota profiles that differentiated diabetes-sensitive from -resistant animals, indicating an association between microbial composition and susceptibility. To test causality, we co-housed sensitive and resistant animals to allow passive microbial cross-transfer and fed the animals with DD. Co-housing led to partial convergence of microbial communities and significantly attenuated the diabetic phenotype in CDs/y rats, supporting a contributory and causal role for the gut microbiome in modulating sensitivity to diabetes. The resistance phenotype, on the other hand, remained unchanged. To distinguish between the contribution of the gut microbiome to susceptibility to diabetes as opposed to the development of the disease, we studied the gut microbial profiles across strains after feeding with DD or RD and the development of diabetes in CDs/y but not in CDr/y. We found distinct taxonomic signatures that differentiated diabetic from non-diabetic animals. These findings demonstrate that the gut microbiome contributes to susceptibility to diabetes with separate pathways from those linked to the development of diabetes and may represent an important modifiable determinant of diabetes risk and a target for early intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Molecular Medicine, Barzilai University Medical Center, Ashkelon 78278, Israel.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba 8410501, Israel.
- The Mantoux Bioinformatics Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot 7632706, Israel.
- Clinical and Research Microbiome Center, Rambam Health Care Campus, Haifa 3109601, Israel.
- Hillel Yaffe Medical Center, Hadera 3820302, Israel.
- Faculty of Medicine, Technion Institute of Technology, Haifa 3109601, Israel.
ORCID-Profile: Chen Ifrach, Amir Szitenberg, Yoram Yagil
Förderung
- Institutional funds
Zitieren
APA
Ifrach, C., Levy-Turgeman, R., Szitenberg, A., Kesten, I., Pitashny, M., Levin-Iaina, N., Segev, Y., & Yagil, Y. (2026). Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes. International Journal of Molecular Sciences, 27(7), 3160. https://doi.org/10.3390/ijms27073160
Vancouver
Ifrach C, Levy-Turgeman R, Szitenberg A, Kesten I, Pitashny M, Levin-Iaina N, et al. Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes. International Journal of Molecular Sciences. 2026;27(7):3160. doi:10.3390/ijms27073160
BibTeX
@article{Ifrach2026,
author = {Ifrach, Chen and Levy-Turgeman, Ruth and Szitenberg, Amir and Kesten, Inbar and Pitashny, Milena and Levin-Iaina, Nomy and Segev, Yael and Yagil, Yoram},
title = {Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3160},
doi = {10.3390/ijms27073160}
}
EUVIMED